COPENHAGEN: Danish pharmaceutical giant and weight loss drugmaker Novo Nordisk said Thursday net profit had risen by 28 percent in the first quarter.

Pharma Bureau seeks ‘CPI-adjusted’ prices for medicines

A company statement said net profit stood at 25.4 billion kroner (3.4 billion euros) while turnover rose 28 percent to 65.3 billion kroner.